Insulin aspart, recombinant Subcutaneous and Mycophenolate Intravenous
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Mycophenolate Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: mycophenolate mofetil
Brand name: Cellcept, Myfortic, MMF
Synonyms: Mycophenolate mofetil (oral/injection), Mycophenolate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Mycophenolate mofetil
- Insulin aspart, recombinant Subcutaneous-Mycophenolate Mofetil Capsules
- Insulin aspart, recombinant Subcutaneous-Mycophenolate Mofetil Injection
- Insulin aspart, recombinant Subcutaneous-Mycophenolate Mofetil Injection Solution
- Insulin aspart, recombinant Subcutaneous-Mycophenolate Mofetil Oral Suspension
- Insulin aspart, recombinant Subcutaneous-Mycophenolate mofetil oral/injection
- Mycophenolate Intravenous-Insulin degludec
- Mycophenolate Intravenous-Insulin Degludec (U-100) Prefilled Pens
- Mycophenolate Intravenous-Insulin Degludec (U-100) Vials
- Mycophenolate Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Mycophenolate Intravenous-Insulin degludec and liraglutide
- Mycophenolate Intravenous-Insulin degludec and liraglutide Subcutaneous